| Title |
Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial
|
|---|---|
| Published in |
JACC, July 2019
|
| DOI | 10.1016/j.jacc.2019.02.079 |
| Pubmed ID | |
| Authors |
Sonia S. Anand, John W. Eikelboom, Leanne Dyal, Jackie Bosch, Christoph Neumann, Petr Widimsky, Alvaro A. Avezum, Jeffrey Probstfield, Nancy Cook Bruns, Keith A.A. Fox, Deepak L. Bhatt, Stuart J. Connolly, Salim Yusuf, COMPASS Trial Investigators |
X Demographics
The data shown below were collected from the profiles of 90 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 16 | 18% |
| Canada | 5 | 6% |
| United Kingdom | 4 | 4% |
| Spain | 4 | 4% |
| France | 4 | 4% |
| Japan | 2 | 2% |
| India | 2 | 2% |
| Poland | 1 | 1% |
| Indonesia | 1 | 1% |
| Other | 6 | 7% |
| Unknown | 45 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 63 | 70% |
| Scientists | 15 | 17% |
| Practitioners (doctors, other healthcare professionals) | 7 | 8% |
| Science communicators (journalists, bloggers, editors) | 5 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 129 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 17 | 13% |
| Other | 15 | 12% |
| Student > Bachelor | 12 | 9% |
| Student > Doctoral Student | 9 | 7% |
| Student > Ph. D. Student | 9 | 7% |
| Other | 17 | 13% |
| Unknown | 50 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 35% |
| Nursing and Health Professions | 7 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
| Psychology | 4 | 3% |
| Agricultural and Biological Sciences | 2 | 2% |
| Other | 12 | 9% |
| Unknown | 52 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 74. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2022.
All research outputs
#590,845
of 25,870,940 outputs
Outputs from JACC
#1,500
of 16,976 outputs
Outputs of similar age
#12,341
of 365,655 outputs
Outputs of similar age from JACC
#41
of 208 outputs
Altmetric has tracked 25,870,940 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,976 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.1. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,655 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 208 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.